Taysha Gene Therapies, Inc.

NASDAQ:TSHA

1.75 (USD) • At close March 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -89.298-111.566-166.014-174.523-60.011-4.46
Depreciation & Amortization 1.2451.3711.1720.4920.0090
Deferred Income Tax 000000
Stock Based Compensation 13.1037.90518.04318.1843.3540
Change In Working Capital -12.467-18.01218.51828.667-0.1110.54
Accounts Receivables 000000
Inventory 000000
Accounts Payables -2.92-2.295-7.80414.4941.9610
Other Working Capital -9.547-15.71726.32214.173-2.0720.54
Other Non Cash Items 6.19247.28439.89110.13826.033.92
Operating Cash Flow -81.225-73.018-88.39-117.042-30.7290.135
Investing Activities:
Investments In Property Plant And Equipment -0.374-3.869-24.869-21.554-9.0820
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 0.011-3.483-0.061-6.25-90
Investing Cash Flow -0.363-7.352-24.93-21.554-9.0820
Financing Activities:
Debt Repayment 0-3.45039.95700
Common Stock Issued 76.78140.7953.244-0.36165.8540
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -0.096-0.947-1.147-0.874125.210
Financing Cash Flow 76.684136.39352.09739.083291.0640
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -4.90456.023-61.223-99.513251.2530.135
Cash At End Of Period 141.636146.5490.517151.74251.2530.135